Clinical Trial News and Research

RSS

Sinovac completes dosing in phase 1 human clinical testing of SARS vaccine

Sinovac Biotech Ltd. has announced that all 36 subjects of the Phase I human clinical trial for its inactivated SARS vaccine have now been vaccinated with two doses of either SARS vaccine or placebo.

7 Sep 2004

Study looks at the patient-practitioner relationship in complementary and alternative therapies

Why do patients opt for complementary and alternative therapies when they are ill? Is the relationship and communication between a patient and a practitioner as important in the treatment as the complementary treatments prescribed?

6 Sep 2004

Generic tritherapy can be used as a basic treatment for AIDS

A clinical trial, conducted in Cameroon by IRD researchers working with other organizations and supported by the ANRS, has demonstrated that one of the most common combinations currently deployed in Africa, using nevirapine, stavudine and lamivudine, satisfies these criteria.

5 Sep 2004

Benefit of using clot-busting drug tissue plasminogen activator (tPA) for ischemic stroke

An independent review of data from a landmark clinical trial has validated the benefit of using the clot-busting drug tissue plasminogen activator (tPA) for ischemic stroke, when given within three hours of symptom onset under a strict treatment protocol.

2 Sep 2004

National clinical trial on early detection of ovarian cancer available at Massey

Virginia Gov. Mark Warner declared September “Gynecological Cancer Awareness Month” in a certificate of recognition to Virginia Commonwealth University’s Massey Cancer Center.

1 Sep 2004

More women and adolescents needed in HIV vaccine clinical trials

Greater participation of women and adolescents is needed in HIV vaccine clinical trials, according to a group of international experts, who attended a consultation on HIV vaccine trials in Lausanne, Switzerland, from 26-28 August.

1 Sep 2004

Study suggests that patients with pulmonary arterial hypertension may benefit from Thelin therapy

Encysive Pharmaceuticals today announced the presentation of data from a clinical study of Thelin(TM) (sitaxsentan) in pulmonary arterial hypertension (PAH), at the European Society of Cardiology Annual Congress in Munich.

31 Aug 2004

Study suggests intramyocardial injection of cells from bone marrow might be an alternative for heart transplantation

Cardiovascular disease remains the leading cause of morbidity and mortality around the world and patients with end-stage ischemic heart failure carry the highest morbid-mortality rate.

30 Aug 2004

Cinical trial to evaluate breakthrough breast cancer treatment

Virginia Commonwealth University’s Massey Cancer Center will host 20 medical experts from around the United States on Sept. 9 to prepare for a 3,000-patient phase III clinical trial that will evaluate a breakthrough breast cancer treatment.

30 Aug 2004

The proper use of drugs to treat heart disease reduces the need for hospital interventions

Regular attacks of chest pain induced by exercise (angina pectoris) is a common condition caused by blockages of the blood vessels that supply the heart (coronary heart disease).

29 Aug 2004

Atrial fibrillation patients often receive needless treatment

Results of the Euro Heart Survey on atrial fibrillation (AF), demonstrate that many AF patients receive clot-preventing drugs while not at risk for stroke.

29 Aug 2004

Solid evidence that best treatment for multiple sclerosis is pregnancy

For years, doctors have suggested the best treatment for multiple sclerosis is pregnancy. Now, an Oregon study is delivering solid evidence to support the theory.

27 Aug 2004

Yogurt, unfortunately, is not the answer for thrush

The curative power of yogurt to prevent cases of thrush when taking antibiotics has been debunked by a University of Melbourne researcher.

27 Aug 2004

Manuka honey effective treatment for leg ulcers

Leg ulcers are a major problem for many elderly people, but a new study hopes to confirm that manuka honey, which is readily available in most Kiwi homes is an effective treatment.

26 Aug 2004

Phase 1 clinical trial of new anticancer drug from Human Genome Sciences

Human Genome Sciences has begun dosing patients in a Phase 1 clinical trial of HGS-TR2J, a novel agonistic human monoclonal antibody to TRAIL Receptor 2, in patients with advanced solid malignancies.

25 Aug 2004

Powerful new cancer-fighting property of Herceptin

For many patients with advanced breast cancer, the cancer drug Herceptin (trastuzumab) has offered new hope when traditional cancer drugs failed to work, shrinking tumors and sending some patients into remission.

23 Aug 2004

StemCells issued U.S. stem cell patent

StemCells, Inc. has announced that the Company has been issued U.S. patent 6,777,233 for work done at the Company covering composition of matter claims for the human neural stem cell.

23 Aug 2004

Peginterferon and Ribavirin combination promising for those with HIV and HCV

Since the introduction of highly active combination drug therapy for HIV, liver failure attributable to infection with the hepatitis C virus (HCV) has become a leading cause of death among those infected with the virus that causes AIDS.

22 Aug 2004

Research will lead to better treatments for mastocytosis

Tens of millions of people know what it's like to suffer the seasonal torment of allergies, when just a whiff of pollen, mold or dust can set off a chain reaction in the body that causes sniffling, sneezing and coughing.

18 Aug 2004

Catheter delivered devices may be just as effective as drug therapy in treating strokes of unidentified origin

A percutaneous catheter procedure to correct a heart abnormality caused by an open patent foramen ovale (PFO), a flap that should be closed in an adult heart, may be just as effective as drug therapy in treating patients who have had strokes of unidentified origin, perhaps caused by this condition.

18 Aug 2004